Clinical Trials Directory

Trials / Sponsors / Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc.

Industry · 6 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingTo Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With L
Advanced or Metastatic Solid Tumors
Phase 12024-11-18
RecruitingDAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line
Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
Phase 32023-02-27
TerminatedTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors
Melanoma, Solid Tumor, Pilocytic Astrocytoma
Phase 12022-05-02
TerminatedTovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Melanoma, Solid Tumor, CRAF Gene Amplification
Phase 22021-07-15
RecruitingA Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Gra
Low-grade Glioma, Advanced Solid Tumor
Phase 22021-04-22
Approved For MarketingExpanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma
Low-grade Glioma
——